{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:58:07Z","timestamp":1770814687079,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1124\/dmd.111.040709","type":"journal-article","created":{"date-parts":[[2011,7,12]],"date-time":"2011-07-12T06:10:11Z","timestamp":1310451011000},"page":"1967-1976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Conjugation of Synthetic Cannabinoids JWH-018 and JWH-073, Metabolites by Human UDP-Glucuronosyltransferases"],"prefix":"10.1016","volume":"39","author":[{"given":"Krishna C.","family":"Chimalakonda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacie M.","family":"Bratton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vi-Huyen","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan Hui","family":"Yiew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Dineva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy L.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura P.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery H.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Radominska-Pandya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.111.040709_bib1","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1124\/dmd.109.031435","article-title":"Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4","volume":"38","author":"Aprile","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.040709_bib2","doi-asserted-by":"crossref","DOI":"10.1007\/s00216-011-4931-5","article-title":"Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS\/MS-based drug testing","author":"Beuck","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/dmd.111.040709_bib3","first-page":"1","article-title":"Human UGT2B7 catalyzes morphine glucuronidation","volume":"25","author":"Coffman","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.040709_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0090-9556(24)15365-2","article-title":"Analysis of soy isoflavone conjugation in vitro and in human blood using liquid chromatography-mass spectrometry","volume":"28","author":"Doerge","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.040709_bib5","series-title":"Understanding the \u201cSpice\u201d phenomenon","first-page":"1","year":"2009"},{"key":"10.1124\/dmd.111.040709_bib6","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1360-0443.2010.03119.x","article-title":"Warning: legal synthetic cannabinoid-receptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals","volume":"105","author":"Every-Palmer","year":"2010","journal-title":"Addiction"},{"key":"10.1124\/dmd.111.040709_bib7","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J Am Chem Soc"},{"key":"10.1124\/dmd.111.040709_bib8","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jchromb.2011.03.034","article-title":"Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures","volume":"879","author":"Grigoryev","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/dmd.111.040709_bib9","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.111.040709_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2125.2009.03386.x","article-title":"In vitro and in vivo glucuronidation of midazolam in humans","volume":"67","author":"Hyland","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.111.040709_bib11","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1111\/j.1476-5381.1996.tb15639.x","article-title":"Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves","volume":"118","author":"Ishac","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.111.040709_bib12","series-title":"The Science of Marijuana","author":"Iversen","year":"2008"},{"key":"10.1124\/dmd.111.040709_bib13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1124\/dmd.107.018788","article-title":"Resveratrol (trans-resveratrol, 3,5,4\u2032-trihydroxy-trans-stilbene) glucuronidation exhibits atypical enzyme kinetics in various protein sources","volume":"36","author":"Iwuchukwu","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.040709_bib14","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1124\/dmd.109.027391","article-title":"Characterizing the effects of common UDP glucuronosyltransferase (UGT) 1A6 and UGT1A1 polymorphisms on cis- and trans-resveratrol glucuronidation","volume":"37","author":"Iwuchukwu","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.040709_bib15","first-page":"652","article-title":"13-Hydroxy- and 13-oxooctadecadienoic acids: novel substrates for human UDP-glucuronosyltransferases","volume":"29","author":"Jude","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.040709_bib16","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1074\/jbc.M206136200","article-title":"Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purified as an active dimeric enzyme","volume":"278","author":"Kurkela","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.111.040709_bib17","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1124\/dmd.31.9.1117","article-title":"Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases","volume":"31","author":"Kuuranne","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.040709_bib18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2174\/156802609788897844","article-title":"The current status and future perspectives of studies of cannabinoid receptor 1 antagonists as anti-obesity agents","volume":"9","author":"Lee","year":"2009","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/dmd.111.040709_bib19","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.bcp.2006.12.021","article-title":"Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation","volume":"73","author":"Lewis","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.111.040709_bib20","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1194\/jlr.M400103-JLR200","article-title":"Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases","volume":"45","author":"Little","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1124\/dmd.111.040709_bib21","article-title":"Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls","author":"Moller","year":"2010","journal-title":"Drug Test Anal"},{"key":"10.1124\/dmd.111.040709_bib22","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1021\/ac2005636","article-title":"Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine","volume":"83","author":"Moran","year":"2011","journal-title":"Anal Chem"},{"key":"10.1124\/dmd.111.040709_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.schres.2009.12.001","article-title":"The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes","volume":"118","author":"M\u00fcller","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1124\/dmd.111.040709_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jemermed.2010.10.014","article-title":"\u201cSpice\u201d girls: synthetic cannabinoid intoxication","volume":"40","author":"Schneir","year":"2011","journal-title":"J Emerg Med"},{"key":"10.1124\/dmd.111.040709_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.forsciint.2010.04.003","article-title":"Detection of JWH-018 metabolites in smoking mixture post-administration urine","volume":"200","author":"Sobolevsky","year":"2010","journal-title":"Forensic Sci Int"},{"issue":"Suppl 1","key":"10.1124\/dmd.111.040709_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1360-0443.97.s01.7.x","article-title":"Characteristics and problems of 600 adolescent cannabis abusers in outpatient treatment","volume":"97","author":"Tims","year":"2002","journal-title":"Addiction"},{"key":"10.1124\/dmd.111.040709_bib27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/dmd.32.4.413","article-title":"Human UDP-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid","volume":"32","author":"Uchaipichat","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.040709_bib28","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1124\/mol.108.048645","article-title":"Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by UDP-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites","volume":"74","author":"Uchaipichat","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.111.040709_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.toxlet.2010.06.002","article-title":"Spice drugs as a new trend: mode of action, identification and legislation","volume":"197","author":"Vardakou","year":"2010","journal-title":"Toxicol Lett"},{"key":"10.1124\/dmd.111.040709_bib30","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/PEC.0b013e3181e4f416","article-title":"A teenager with agitation: higher than she should have climbed","volume":"26","author":"Vearrier","year":"2010","journal-title":"Pediatr Emerg Care"},{"key":"10.1124\/dmd.111.040709_bib31","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1096\/fasebj.11.11.9285481","article-title":"The Hill equation revisited: uses and misuses","volume":"11","author":"Weiss","year":"1997","journal-title":"FASEB J"},{"key":"10.1124\/dmd.111.040709_bib32","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00216-010-4171-0","article-title":"In vitro phase I metabolism of the synthetic cannabimimetic JWH-018","volume":"398","author":"Wintermeyer","year":"2010","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/dmd.111.040709_bib33","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00216-006-0717-6","article-title":"Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS\/MS","volume":"386","author":"Zhang","year":"2006","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/dmd.111.040709_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1124\/dmd.109.028712","article-title":"Glucuronidation of dihydrotestosterone and trans-androsterone by recombinant UDP-glucuronosyltransferase (UGT) 1A4: evidence for multiple UGT1A4 aglycone binding sites","volume":"38","author":"Zhou","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.040709_bib35","first-page":"464","article-title":"Withdrawal phenomena and dependence syndrome after the consumption of \u201cspice gold.\u201d","volume":"106","author":"Zimmermann","year":"2009","journal-title":"Dtsch Arztebl Int"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562422506X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562422506X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.111.040709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T20:01:50Z","timestamp":1739908910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562422506X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S009095562422506X"],"URL":"https:\/\/doi.org\/10.1124\/dmd.111.040709","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conjugation of Synthetic Cannabinoids JWH-018 and JWH-073, Metabolites by Human UDP-Glucuronosyltransferases","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.111.040709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}